Therapeutic Treatment for Benign Prostatic Hyperplasia (Hardcover)

The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90 per cent of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - the Textbook of Benign Prostatic Hyperplasia, 2nd edition - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.

General

Imprint:	Crc Press
Country of origin:	United Kingdom
Release date:	June 2005
First published:	July 2005
Editors:	Roger S. Kirby • John D. McConnell • John Fitzpatrick • Claus G. Roehrborn • Michael Wyllie • Peter Boyle
Dimensions:	246 x 189 x 16mm (L x W x T)
Format:	Hardcover
Pages:	202
ISBN-13:	978-1-84184-601-9
Categories:	Books > Medicine > General issues > General Promotions
LSN:	1-84184-601-5
Barcode:	9781841846019

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!